BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 23, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

In the clinic for Jan. 27, 2026

Jan. 27, 2026
Clinical updates, including data readouts and publications: Eledon, Immunitybio, Privo, Sarepta, Taurx, United, Vivus.
Read More

Financings for Jan. 27, 2026

Jan. 27, 2026
Biopharmas raising money in public or private financings, including: Corvus, Erasca, Fortitue, Primmune.
Read More

Appointments and advancements for Jan. 27, 2026

Jan. 27, 2026
New hires and promotions in the biopharma industry, including: Frazier, Janux, Realta.
Read More

Appointments and advancements for Jan. 27, 2026

Jan. 27, 2026
New hires and promotions in the med-tech industry, including: Cyrex Medical, Cleveland Diagnostics, Nucleic AI, Pixelgen, Prollenium, Qiagen, Quibim, Voxcell.
Read More

Financings for Jan. 27, 2026

Jan. 27, 2026
Med-tech firms raising money in public or private financings, including: 4dmedical, Samantree, Implantica, Nanalysis Scientific, Turbett Surgical.
Read More

In the clinic for Jan. 27, 2026

Jan. 27, 2026
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Hyperfine, Myriad Genetics, Tempus AI.
Read More

Other news to note for Jan. 27, 2026

Jan. 27, 2026
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bluejay Diagnostics, Burl Concepts, Imagine Devices, Neotech, Robocath, Siemens Healthineers.
Read More

Regulatory actions for Jan. 27, 2026

Jan. 27, 2026
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abanza, Outset Medical, Spine Innovation.
Read More

Appointments and advancements for Jan. 27, 2026

Jan. 27, 2026
New hires and promotions in the med-tech industry, including: Daiichi Sankyo, Nxera Pharma.
Read More

Financings for Jan. 27, 2026

Jan. 27, 2026
Biopharmas in Asia-Pacific raising money in public or private financings: Corxel, Harbour Biomed, Sprice Biosciences, Vincentage.
Read More
Previous 1 2 … 37 38 39 40 41 42 43 44 45 … 1784 1785 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 22, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing